TEM earnings analysis
What we found in TEM's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Tempus AI, Inc. reported a strong Q1 2026 with revenue of $348.1 million, exceeding consensus estimates of $345.5 million, and reflecting a 36% year-over-year increase. However, the company incurred a net loss of $125.9 million, larger than prior projections, alongside significant stock-based compensation expenses, impacting overall profitability.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth
- Total revenue increased by 36% year-over-year to $348.1 million in Q1 2026.
- Diagnostics Segment Expanded
- Diagnostics revenue rose to $261.1 million from $193.8 million year-over-year.
- Data and Applications Uptrend
- Revenue from Data and applications grew to $87.0 million, a 40% increase year-over-year.
- Cash Position Above $500M
- Cash and cash equivalents amounted to $521.2 million, down from $604.8 million.
- Improved Cash Burns
- Operating cash flow improved to a net cash used of $73.3 million from $105.6 million in the prior year.
- Full Year Guidance Raised
- Management increased full-year revenue guidance to $1.59-$1.60 billion, projecting ~25% annual growth.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Larger Net Loss
- Net loss of $125.9 million for Q1 2026, exceeding the expected loss of $0.25 per share.
- High Stock-Based Compensation
- Stock-based compensation rose significantly to $52.7 million, up from $23 million prior year.
- Liquidity Risks
- Ongoing cash usage of $73.3 million raises concerns about future liquidity amidst continued losses.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.71
- Gross margin
- 64.7%
- Operating margin
- -24.3%
- Segment
- Diagnostics: $261.1 million
- Segment
- Data and applications: $87.0 million
What they said about what is next.
Management increased full-year revenue guidance to $1.59 billion - $1.60 billion.
The filing reads about the same as the one before it.
What came before.
- 10-Q · November 4, 2025
- Tempus AI, Inc. reported Q3 2025 results with total revenue of $334.2 million, representing a significant growth from $180.9 million in Q3 2024. Although the company sustained a net loss of $80 million, the improvement…
- 10-Q · August 8, 2025
- Tempus AI, Inc. reported better-than-expected Q2 2025 results with revenues of $314.635 million, exceeding estimates of $298.385 million, and an EPS loss of $-0.22 compared to the consensus estimate of -$0.34. This…
- 10-Q · May 6, 2025
- Tempus AI, Inc. reported strong revenue growth in Q1 2025, achieving $255.7 million, a 75% increase from $145.8 million in Q1 2024, driven by a surge in Genomics and Data services revenues. Despite this growth, the…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing TEM makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever